182 related articles for article (PubMed ID: 30879230)
1. Therapeutic Prospective of a Spore-Forming Probiotic-Bacillus clausii UBBC07 Against Acetaminophen-Induced Uremia in Rats.
Patel C; Patel P; Acharya S
Probiotics Antimicrob Proteins; 2020 Mar; 12(1):253-258. PubMed ID: 30879230
[TBL] [Abstract][Full Text] [Related]
2. Safety assesment of
Lakshmi SG; Jayanthi N; Saravanan M; Ratna MS
Toxicol Rep; 2017; 4():62-71. PubMed ID: 28959626
[TBL] [Abstract][Full Text] [Related]
3. Comparative accounts of probiotic properties of spore and vegetative cells of
Ahire JJ; Kashikar MS; Madempudi RS
3 Biotech; 2021 Mar; 11(3):116. PubMed ID: 33604232
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of probiotics - Lactobacillus plantarum UBLP40 and Bacillus clausii UBBC07 on thioacetamide-induced acute hepatic encephalopathy in rats.
Shahgond L; Patel C; Thakur K; Sarkar D; Acharya S; Patel P
Metab Brain Dis; 2022 Jan; 37(1):185-195. PubMed ID: 34731397
[TBL] [Abstract][Full Text] [Related]
5. Probiotic Bacillus Spores Protect Against Acetaminophen Induced Acute Liver Injury in Rats.
Neag MA; Catinean A; Muntean DM; Pop MR; Bocsan CI; Botan EC; Buzoianu AD
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32120994
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of uremia by orally feeding alpha-lipoic acid on acetaminophen induced uremic rats.
Pradhan S; Mandal S; Roy S; Mandal A; Das K; Nandi DK
Saudi Pharm J; 2013 Apr; 21(2):187-92. PubMed ID: 23960834
[TBL] [Abstract][Full Text] [Related]
7. Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection.
Paparo L; Tripodi L; Bruno C; Pisapia L; Damiano C; Pastore L; Berni Canani R
Sci Rep; 2020 Jul; 10(1):12636. PubMed ID: 32724066
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Bacillus clausii UBBC - 07 spores in the amelioration of oral mucositis in head and neck cancer patients undergoing radiation therapy.
Mirza MA; Aruna D; Irukulla M
Cancer Treat Res Commun; 2022; 31():100523. PubMed ID: 35101832
[TBL] [Abstract][Full Text] [Related]
9. Bacillus clausii UBBC-07 reduces severity of diarrhoea in children under 5 years of age: a double blind placebo controlled study.
Sudha MR; Jayanthi N; Pandey DC; Verma AK
Benef Microbes; 2019 Mar; 10(2):149-154. PubMed ID: 30638396
[TBL] [Abstract][Full Text] [Related]
10. The Comparative Effects of Inulin and
Sogut I; Kar F; Tanrikulu-Kucuk S; Gozden TT; Asena Can S; Kandil A
J Invest Surg; 2022 Jun; 35(6):1322-1328. PubMed ID: 35313790
[TBL] [Abstract][Full Text] [Related]
11. Survival and Germination of
Ahire JJ; Kashikar MS; Madempudi RS
Front Microbiol; 2020; 11():1010. PubMed ID: 32733389
[No Abstract] [Full Text] [Related]
12. Quantitative and qualitative characterization of commercially available oral suspension of probiotic products containing Bacillus Clausii spores.
Kharwar A; Bazaz MR; Dandekar MP
BMC Microbiol; 2022 Sep; 22(1):217. PubMed ID: 36114449
[TBL] [Abstract][Full Text] [Related]
13. In vivo assessment of bacteriotherapy on acetaminophen-induced uremic rats.
Mandal A; Das K; Roy S; Mondal KCh; Nandi DK
J Nephrol; 2013; 26(1):228-36. PubMed ID: 22782327
[TBL] [Abstract][Full Text] [Related]
14. Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina
Khatri I; Sharma G; Subramanian S
BMC Microbiol; 2019 Dec; 19(1):307. PubMed ID: 31888501
[TBL] [Abstract][Full Text] [Related]
15. Secreted Compounds of the Probiotic Bacillus clausii Strain O/C Inhibit the Cytotoxic Effects Induced by Clostridium difficile and Bacillus cereus Toxins.
Ripert G; Racedo SM; Elie AM; Jacquot C; Bressollier P; Urdaci MC
Antimicrob Agents Chemother; 2016 Jun; 60(6):3445-54. PubMed ID: 27001810
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of different commercially available synbiotic on acetaminophen-induced uremic rats.
Mandal A; Patra A; Mandal S; Roy S; Mahapatra SD; Mahapatra TD; Paul T; Das K; Mondal KC; Nandi DK
Clin Exp Nephrol; 2015 Apr; 19(2):168-77. PubMed ID: 24740592
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory and Antioxidant Properties of a Novel Potential Probiotic
Khokhlova E; Colom J; Simon A; Mazhar S; García-Lainez G; Llopis S; Gonzalez N; Enrique-López M; Álvarez B; Martorell P; Tortajada M; Deaton J; Rea K
Microorganisms; 2023 Jan; 11(2):. PubMed ID: 36838205
[TBL] [Abstract][Full Text] [Related]
18. Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation.
Ghelardi E; Celandroni F; Salvetti S; Gueye SA; Lupetti A; Senesi S
J Appl Microbiol; 2015 Aug; 119(2):552-9. PubMed ID: 25973914
[TBL] [Abstract][Full Text] [Related]
19. Bacillus clausii for Prevention of Late-onset Sepsis in Preterm Infants: A Randomized Controlled Trial.
Tewari VV; Dubey SK; Gupta G
J Trop Pediatr; 2015 Oct; 61(5):377-85. PubMed ID: 26246087
[TBL] [Abstract][Full Text] [Related]
20. Microbiological and molecular characterization of commercially available probiotics containing Bacillus clausii from India and Pakistan.
Patrone V; Molinari P; Morelli L
Int J Food Microbiol; 2016 Nov; 237():92-97. PubMed ID: 27543819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
